Schroder Investment Management Group Acquires Shares of 117,356 Luminex Co. (LMNX)

Share on StockTwits

Schroder Investment Management Group acquired a new stake in Luminex Co. (NASDAQ:LMNX) during the 3rd quarter, HoldingsChannel.com reports. The fund acquired 117,356 shares of the medical instruments supplier’s stock, valued at approximately $3,557,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. raised its stake in shares of Luminex by 0.8% in the third quarter. BlackRock Inc. now owns 6,644,013 shares of the medical instruments supplier’s stock valued at $201,379,000 after acquiring an additional 50,973 shares in the last quarter. Acadian Asset Management LLC raised its stake in shares of Luminex by 3.7% in the third quarter. Acadian Asset Management LLC now owns 1,635,083 shares of the medical instruments supplier’s stock valued at $49,560,000 after acquiring an additional 58,487 shares in the last quarter. Northern Trust Corp raised its stake in shares of Luminex by 1.3% in the second quarter. Northern Trust Corp now owns 967,694 shares of the medical instruments supplier’s stock valued at $28,575,000 after acquiring an additional 12,587 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Luminex by 1.5% in the third quarter. Bank of New York Mellon Corp now owns 682,988 shares of the medical instruments supplier’s stock valued at $20,701,000 after acquiring an additional 10,250 shares in the last quarter. Finally, Bessemer Group Inc. raised its stake in shares of Luminex by 949.0% in the third quarter. Bessemer Group Inc. now owns 531,851 shares of the medical instruments supplier’s stock valued at $16,121,000 after acquiring an additional 481,151 shares in the last quarter. Institutional investors and hedge funds own 83.82% of the company’s stock.

Luminex stock opened at $28.42 on Friday. Luminex Co. has a 1-year low of $18.62 and a 1-year high of $35.37. The firm has a market capitalization of $1.30 billion, a price-to-earnings ratio of 31.23, a price-to-earnings-growth ratio of 3.37 and a beta of 0.35.

Luminex (NASDAQ:LMNX) last posted its quarterly earnings results on Monday, November 5th. The medical instruments supplier reported $0.05 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.03). Luminex had a net margin of 5.65% and a return on equity of 5.99%. The business had revenue of $72.40 million during the quarter, compared to analyst estimates of $74.05 million. During the same quarter in the prior year, the business earned $0.13 earnings per share. The firm’s quarterly revenue was down 2.3% on a year-over-year basis. Equities research analysts predict that Luminex Co. will post 0.58 EPS for the current year.

A number of analysts have weighed in on the company. Zacks Investment Research upgraded Luminex from a “sell” rating to a “hold” rating in a research note on Tuesday, October 9th. ValuEngine upgraded Luminex from a “buy” rating to a “strong-buy” rating in a research note on Monday, October 29th. BidaskClub upgraded Luminex from a “hold” rating to a “buy” rating in a research note on Wednesday, October 17th. Finally, Citigroup cut their price target on Luminex from $34.00 to $33.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 6th. Five equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company. Luminex has a consensus rating of “Buy” and a consensus price target of $28.40.

ILLEGAL ACTIVITY NOTICE: “Schroder Investment Management Group Acquires Shares of 117,356 Luminex Co. (LMNX)” was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4001260/schroder-investment-management-group-acquires-shares-of-117356-luminex-co-lmnx.html.

Luminex Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; and VERIGENE system, an automated multiplex-capable system.

Recommended Story: Technical Analysis

Want to see what other hedge funds are holding LMNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Luminex Co. (NASDAQ:LMNX).

Institutional Ownership by Quarter for Luminex (NASDAQ:LMNX)

Receive News & Ratings for Luminex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Schroder Investment Management Group Acquires Shares of 117,356 Luminex Co.
Schroder Investment Management Group Acquires Shares of 117,356 Luminex Co.
Baidu  Reaches New 52-Week Low at $174.66
Baidu Reaches New 52-Week Low at $174.66
Carbon Black  Hits New 12-Month Low at $14.54
Carbon Black Hits New 12-Month Low at $14.54
WABnetwork Price Tops $0.0001 on Top Exchanges
WABnetwork Price Tops $0.0001 on Top Exchanges
Breakout Stake   Trading 23.6% Lower  This Week
Breakout Stake Trading 23.6% Lower This Week
Critical Contrast: HANG SENG Bk Lt/S  vs. Royal Bank of Scotland Group
Critical Contrast: HANG SENG Bk Lt/S vs. Royal Bank of Scotland Group


Leave a Reply

© 2006-2018 Ticker Report